Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia

Blood

Volumn 95, Issue 2, 2000, Pages 651-659

  Capello, Daniela ^b   Vitolo, Umberto ^b   Pasqualucci, Laura ^b   Quattrone, Silvia ^b   Migliaretti, Giuseppe ^b   Fassone, Lucia ^b   Ariatti, Cristiano ^b   Vivenza, Daniela ^b   Gloghini, Annunziata ^b   Pastore, Cristina ^b   Lanza, Carlo ^b   Nomdedeu, Josep ^b   Botto, Barbara ^b   Freilone, Roberto ^b   Buonaiuto, Daniela ^b   Zagonel, Vittorina ^b   Gallo, Eugenio ^b   Palestro, Giorgio ^b   Saglio, Giuseppe ^b   Dalla Favera, Riccardo ^b   Carbone, Antonino ^b   Gaidano, Gianluca ^a   more..

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; CD5 ANTIGEN; DNA; IMMUNOGLOBULIN; PROTEIN BCL 6;

ARTICLE; B CELL LYMPHOMA; CONTROLLED STUDY; DNA SEQUENCE; GENE; GENE SEQUENCE; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SURVIVAL;

BASE SEQUENCE; DNA-BINDING PROTEINS; HUMANS; LEUKEMIA, B-CELL; LYMPHOMA, B-CELL; MUTATION; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-6; PROTO-ONCOGENES; SURVIVAL RATE; TRANSCRIPTION FACTORS;

EID: 12944255838     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Ye BH, Lista F, Lo Coco F, et al. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science. 1993;262:747.
2. Baron BW, Nucifora G, McCabe N, Espinosa III R, Le Beau MM, McKeithan TW. Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3; 22)(q27;q11) in B-cell lymphomas. Proc Natl Acad Sci USA. 1993;90:5262.
3. Kerckaert J-P, Deweindt C, Tilly H, Quief S, Lecocq G, Bastard C. LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nat Genet. 1993;5:66.
4. Cattoretti G, Chang CC, Cechova K, et al. BCL-6 protein is expressed in germinal-center B cells. Blood. 1995;86:45.
5. Dent AL, Shaffer AL, Yu X, Allman D, Staudt LM. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science. 1997;276:589.
6. Ye BH, Cattoretti G, Shen Q, et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet. 1997; 16:161.
7. Ye BH, Chaganti S, Chang CC, et al. Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma. EMBO J. 1995;14:6209.
8. Bastard C, Deweindt C, Kerckaert JP, et al. LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients. Blood. 1994;83:2423.
9. Lo Coco F, Ye BH, Lista F, et al. Rearrangements ot the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. Blood. 1994;83:1757.
10. Offit K, Lo Coco F, Louie DC, et al. Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. N Engl J Med. 1994; 331:74.
11. Volpe G, Vitolo U, Carbone A, et al. Molecular heterogeneity of B-lineage diffuse large cell lymphoma. Genes Chromosomes Cancer. 1996; 16:21.
12. Migliazza A, Martinotti S, Chen W, et al. Frequent somatic hypermutation of the 5′ noncoding region of the BCL-6 gene in B-cell lymphoma. Proc Natl Acad Sci USA. 1995;92:12,520.
13. Pasqualucci L, Migliazza A, Fracchiolla N, et al. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci USA. 1998;95: 11,816.
14. Shen HM, Peters A, Baron B, Zhu X, Storb U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science. 1998;280:1750.
15. Peng H-Z, Du M-Q, Koulis A, et al. Nonimmunoglobulin gene hypermutation in germinal center B cells. Blood. 1999;93:2167.
16. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361.
17. Non-Hodgkin's lymphoma pathologic classification project. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas: summary and description of a Working Formulation for clinical usage. Cancer. 1982;49:2112.
18. Kuppers R, Rajewsky K, Hansmann M-L. Diffuse large cell lymphomas are derived from mature B cells carrying V region genes with a high load of somatic mutation and evidence of selection for antibody expression. Eur J Immunol. 1997;27: 1398.
19. Fais F, Gaidano G, Capello D, et al. Immunoglobulin V region gene use and structure suggest antigen selection in AIDS-related primary effusion lymphomas. Leukemia. 1999;13:1093.
20. Vitolo U, Gaidano G, Botto B, et al. Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: clinical relevance in 71 patients. Ann Oncol. 1998;9:55.
21. Kaplan EL, Meier P. Nonparametric estimation from incomplete information. J Am Stat Assoc. 1958;53:547.
22. Rogozin IB, Kolchanov NA. Somatic hypermutagenesis in immunoglobulin genes. II. Influence of neighboring base sequences on mutagenesis. Biochim Biophys Acta. 1992;1171:11.
23. Smith DS, Creadon G, Jena PK, Portanova JP, Kotzin BL, Wysocki LJ. Di- and trinucleotide preferences of somatic mutagenesis in normal and autoreactive B cells. J Immunol. 1996;156:2642.
24. Dorner T, Foster SJ, Farner NL, Lipsky PE. Somatic hypermutation of immunogobulin heavy chain genes: targeting of RGYW motifs on both DNA strands. Eur J Immunol. 1998;28:3384.
25. Zelenetz AD, Chen TT, Levy R. Clonal expansion in follicular lymphoma occurs subsequent to antigen selection. J Exp Med. 1992;176:1137.
26. κ gene usage but different degrees of somatic mutation in hairy cell leukemia, prolymphocytic leukemia, Waldenstrom's macroglobulinemia, and myeloma. Blood. 1994;83:3647.
27. Qin Y, Greiner A, Trunk MJF, Schmausser B, Ott MM, Muller-Hermelink HK. Somatic hypermutation in low-grade mucosa-associated lymphoid tissue-type B-cell lymphoma. Blood. 1995;86:3528.
28. Tamaru J, Hummel M, Marafioti T, et al. Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations. Am J Pathol. 1995;147:1398.
29. H genes of high-grade mucosa-associated lymphoid tissue lymphomas show a high load of somatic mutations and evidence of antigen-dependent affinity maturation. Lab Invest. 1998;78:277.
30. Muller-Hermelink HK, Greiner A. Molecular analysis of human immunoglobulin heavy chain variable genes (IgVH) in normal and malignant B cells. Am J Pathol. 1998;153:1341.
31. Maloum K, Magnac C, Azgui Z, et al. VH gene expression in hairy cell leukemia. Br J Haematol. 1998;101:171.
32. Miranda RN, Cousar JB, Hammer RD, Collins RD, Vnencak-Jones L. Somatic mutation analysis of IgH variable regions reveals that tumor cells of most parafollicular (monocytoid) B-cell lymphoma, splenic marginal zone B-cell lymphoma, and some hairy cell leukemia are composed of memory B lymphocytes. Hum Pathol. 1999;30:306.
33. Zupo S, Isnardi L, Megna M, et al. CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis. Blood. 1996;88:1365.
34. Fais F, Ghiotto F, Hashimoto S, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest. 1998;102:1515.
35. Taniguchi M, Oka K, Hiasa A, et al. De novo CD5+ diffuse B-cell lymphomas express VH genes with somatic mutation. Blood. 1998;91: 1145.
36. Addis B, Isaacson P. Large cell lymphoma of the mediastinum: A B-cell tumor of probable thymic origin. Histopathology. 1986;10:379.
37. Hofmann W, Momburg F, Moller P, Otto H. Intra-and extrathymic B cells in physiologic and pathologic conditions. Immunohistochemical study on normal thymus and lymphofollicular hyperplasia ot the thymus. Virchows Arch [A]. 1988;412:431.
38. Tsang P, Cesarman E, Chadbum A, Liu YF, Knowles DM. Molecular characterization of primary mediastinal B cell lymphoma. Am J Pathol. 1996;148:2017.
39. Betz AG, Neuberger MS, Milstein C. Discriminating intrinsic and antigen-selected mutational hotspots in immunoglobulin V genes. Immunol Today. 1993;14:405.
40. Wagner SD, Neuberger MS. Somatic hypermutation of immunoglobulin genes. Annu Rev Immunol. 1996;14:441.
41. Kelsoe G. V(D)J hypermutation and receptor revision: coloring outside the lines. Curr Opin Immunol. 1999;11:70.
42. Yelamos J, Klix N, Goyenechea B, Lozano F, et al. Targeting of non- Ig sequences in place of V segment by somatic hypermutation. Nature. 1995;376:225.
43. Storb U, Peters A, Klotz E, Kim N, et al. Immunoglobulin transgenes as targets for somatic hypermutation. Int J Dev Biol. 1998;42:977.
44. Betz AG, Rada C, Pannell R, Milstein C, Neuberger MS. Passenger transgenes reveal intrinsic specificity of the antibody hypermutation mechanism: clustering, polarity, and specific hot spots. Proc Natl Acad Sci USA. 1993;90:2385.